Understanding clinical trials: terms, phases, and how to check early fit
A basic explanation of clinical trial phases, recruitment status, and why a recruiting registry record does not mean an international patient can automatically join.
Prepared and published by TanyaKanker
For: Patients and families considering a clinical trial
Medical review status
30-second answer
The key point
A basic explanation of clinical trial phases, recruitment status, and why a recruiting registry record does not mean an international patient can automatically join.
This is an educational summary, not a diagnosis or final treatment recommendation.
What a clinical trial is
A clinical trial is research in humans designed to answer a specific question, such as whether a medicine is safe, whether it helps, and what dose can be tolerated.
Participants follow examinations and monitoring defined in a protocol. That protocol decides who can and cannot take part.
Research phases
Early phase trials usually focus on safety and dose finding. Later phase trials more often compare benefit and risk against an existing standard.
Participant numbers, monitoring, and risk differ by phase, so the questions a patient should ask also differ.
- Early phase: assesses safety, tolerability, and dose.
- Middle phase: assesses activity in a defined group.
- Later phase: compares benefit and risk with a comparator treatment.
Penjelasan visual
Read one study step by step
A reading sequence that helps you assess a study page in a few minutes.
This diagram explains the sequence of assessment and discussion. It is not treatment advice or an eligibility decision.
Read the title and phase
The phase indicates how far testing has progressed.
Check the main criteria
The criteria define who may and may not participate.
Compare them with your records
Note any criteria you cannot yet confirm.
Contact the study centre
Only the study centre can assess eligibility.
Follow the screening process
This includes additional tests and the consent explanation.
Read study criteria as a checklist, not as an assessment of your eligibility.
Registry status is not access status
A public registry records whether a study is recruiting. It does not prove that a person from another country can enrol.
Some studies accept only local residents for insurance, administration, or monitoring reasons. International access must be confirmed directly with the study site.
- Registry status: whether a study is listed as recruiting.
- Site status: whether a site has been verified and is actively operating.
- International access status: whether patients from outside the country can be accepted.
Documents usually requested
Document requests vary by study, but most teams ask for a disease history summary, pathology report, biomarker results, and recent imaging.
Clear, complete digital files can shorten the first review.
Questions to ask
Specific questions help the study team assess the file and help the patient understand what participation would involve.
- What is the study goal and what treatment is used as the comparator?
- Are patients from outside the country accepted, and under what conditions?
- What tests and visits are required, and for how long?
- How are costs covered, and what remains the participant's responsibility?
- What happens if the condition worsens or the participant decides to stop?
Langkah berikutnya
If you have medical reports, build a case summary so your documents and questions are organised before consultation.